These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 25422210)
1. Expression and clinical significance of miRNA-34a in colorectal cancer. Ma ZB; Kong XL; Cui G; Ren CC; Zhang YJ; Fan SJ; Li YH Asian Pac J Cancer Prev; 2014; 15(21):9265-70. PubMed ID: 25422210 [TBL] [Abstract][Full Text] [Related]
2. MicroRNAs associated with initiation and progression of colonic polyp: a feasibility study. Aslam MI; Hussein S; West K; Singh B; Jameson JS; Pringle JH Int J Surg; 2015 Jan; 13():272-279. PubMed ID: 25496852 [TBL] [Abstract][Full Text] [Related]
3. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195 [TBL] [Abstract][Full Text] [Related]
4. Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells. Ng L; Li X; Wan TM; Iyer D; Sin RW; Lo OS; Foo DC; Law WL Eur J Surg Oncol; 2022 Jan; 48(1):245-252. PubMed ID: 34620510 [TBL] [Abstract][Full Text] [Related]
5. Relationship between Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression. Slattery ML; Herrick JS; Pellatt DF; Stevens JR; Mullany LE; Wolff E; Hoffman MD; Samowitz WS; Wolff RK Carcinogenesis; 2016 Mar; 37(3):245-261. PubMed ID: 26740022 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA Signatures of Colonic Polyps on Screening and Histology. Tsikitis VL; Potter A; Mori M; Buckmeier JA; Preece CR; Harrington CA; Bartley AN; Bhattacharyya AK; Hamilton SR; Lance MP; Thompson PA Cancer Prev Res (Phila); 2016 Dec; 9(12):942-949. PubMed ID: 27658891 [TBL] [Abstract][Full Text] [Related]
9. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783 [TBL] [Abstract][Full Text] [Related]
10. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas. Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401 [TBL] [Abstract][Full Text] [Related]
11. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer. Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433 [TBL] [Abstract][Full Text] [Related]
12. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value. Rapti SM; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481 [TBL] [Abstract][Full Text] [Related]
13. Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression. Aherne ST; Madden SF; Hughes DJ; Pardini B; Naccarati A; Levy M; Vodicka P; Neary P; Dowling P; Clynes M BMC Cancer; 2015 Apr; 15():329. PubMed ID: 25924769 [TBL] [Abstract][Full Text] [Related]
14. Benign serrated colorectal fibroblastic polyps/intramucosal perineuriomas are true mixed epithelial-stromal polyps (hybrid hyperplastic polyp/mucosal perineurioma) with frequent BRAF mutations. Agaimy A; Stoehr R; Vieth M; Hartmann A Am J Surg Pathol; 2010 Nov; 34(11):1663-71. PubMed ID: 20962618 [TBL] [Abstract][Full Text] [Related]
15. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection. Slaby O Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899 [TBL] [Abstract][Full Text] [Related]
16. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853 [TBL] [Abstract][Full Text] [Related]
17. Low diacylglycerol values in colonic adenomas and colorectal cancer. Sauter G; Nerlich A; Spengler U; Kopp R; Pfeiffer A Gut; 1990 Sep; 31(9):1041-5. PubMed ID: 2210451 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells. Chandrasekaran KS; Sathyanarayanan A; Karunagaran D Tumour Biol; 2016 Oct; 37(10):13155-13166. PubMed ID: 27456356 [TBL] [Abstract][Full Text] [Related]
19. Genetic instability, CpG island methylator phenotype, and proliferative activity are distinct differences between diminutive and small tubular adenoma of the colorectum. Nando Y; Watari J; Ito C; Hara K; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Tomita T; Ohda Y; Oshima T; Fukui H; Matsubara N; Tomita N; Hirota S; Miwa H Hum Pathol; 2017 Feb; 60():37-45. PubMed ID: 27746269 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]